B

Bioventus Inc
NASDAQ:BVS

Watchlist Manager
Bioventus Inc
NASDAQ:BVS
Watchlist
Price: 11.13 USD -0.27% Market Closed
Market Cap: 901.2m USD
Have any thoughts about
Bioventus Inc?
Write Note

Bioventus Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bioventus Inc
Interest Income Expense Peer Comparison

Comparables:
HAE
ICUI
ALGN
LNTH
MMSI

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioventus Inc
NASDAQ:BVS
Interest Income Expense
-$38.6m
CAGR 3-Years
-62%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Interest Income Expense
-$8.5m
CAGR 3-Years
23%
CAGR 5-Years
9%
CAGR 10-Years
2%
ICU Medical Inc
NASDAQ:ICUI
Interest Income Expense
-$105.9m
CAGR 3-Years
-709%
CAGR 5-Years
-61%
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Interest Income Expense
$16.7m
CAGR 3-Years
83%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Lantheus Holdings Inc
NASDAQ:LNTH
Interest Income Expense
$15m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merit Medical Systems Inc
NASDAQ:MMSI
Interest Income Expense
-$4.8m
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
7%

See Also

What is Bioventus Inc's Interest Income Expense?
Interest Income Expense
-38.6m USD

Based on the financial report for Dec 31, 2023, Bioventus Inc's Interest Income Expense amounts to -38.6m USD.

What is Bioventus Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-16%

Over the last year, the Interest Income Expense growth was -56%. The average annual Interest Income Expense growth rates for Bioventus Inc have been -62% over the past three years , -16% over the past five years .

Back to Top